BIS vs. VGT
BIS (ProShares UltraShort Nasdaq Biotechnology) and VGT (Vanguard Information Technology ETF) are both exchange-traded funds - BIS is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (-200%), while VGT is a Technology Equities fund tracking the MSCI USA IMI Information Technology 25/50 Index. Both are passively managed. Over the past 10 years, BIS returned -24.02%/yr vs 24.06%/yr for VGT. Their -0.55 correlation means they have often moved in opposite directions in the past. BIS charges 0.95%/yr vs 0.09%/yr for VGT.
Performance
BIS vs. VGT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIS achieves a -24.85% return, which is significantly lower than VGT's 20.36% return. Over the past 10 years, BIS has underperformed VGT with an annualized return of -24.02%, while VGT has yielded a comparatively higher 24.06% annualized return.
BIS
- 1D
- 3.65%
- 1M
- 9.65%
- 6M
- -20.75%
- YTD
- -24.85%
- 1Y
- -53.59%
- 3Y*
- -27.87%
- 5Y*
- -15.63%
- 10Y*
- -24.02%
- ALL TIME*
- -32.48%
VGT
- 1D
- -0.38%
- 1M
- -1.30%
- 6M
- 21.30%
- YTD
- 20.36%
- 1Y
- 34.81%
- 3Y*
- 26.48%
- 5Y*
- 17.81%
- 10Y*
- 24.06%
- ALL TIME*
- 14.84%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $67.10K | $102.51K | $113.13K | |
| $440.89M | $515.41M | $573.34M |
BIS vs. VGT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | -24.85% | -45.95% | 4.79% | -6.54% | -2.14% | -14.74% | -56.01% | -41.01% | 5.14% | -36.98% |
VGT Vanguard Information Technology ETF | 20.36% | 21.77% | 29.30% | 52.66% | -29.70% | 30.45% | 46.04% | 48.62% | 2.46% | 37.08% |
Correlation
The correlation between BIS and VGT is -0.28, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.28 |
Correlation (3Y) Balances recent behavior with more history. | -0.38 |
Correlation (5Y) Shows whether the relationship held over a longer period. | -0.49 |
Correlation (10Y) Provides a long-term view across more market conditions. | -0.54 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2010 | -0.55 |
Over the past year, the inverse relationship between BIS and VGT has weakened: their correlation has moved from -0.55 to -0.28, meaning they move in opposite directions less often than they have historically.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIS vs. VGT — Risk / Return Rank
BIS
VGT
BIS vs. VGT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and Vanguard Information Technology ETF (VGT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIS | VGT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.64 | ||
| Sortino ratioReturn per unit of downside risk | -4.04 | ||
| Omega ratioGain probability vs. loss probability | 0.76 | 1.23 | -0.46 |
| Calmar ratioReturn relative to maximum drawdown | -0.91 | 1.94 | -2.85 |
| Martin ratioReturn relative to average drawdown | -1.38 | 5.23 | -6.61 |
Loading charts...
Drawdowns
BIS vs. VGT - Drawdown Comparison
The maximum BIS drawdown since its inception was -99.89%, which is greater than VGT's maximum drawdown of -54.63%. Use the drawdown chart below to compare losses from any high point for BIS and VGT.
Loading charts...
Drawdown Indicators
| BIS | VGT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.89% | -54.63% | -45.26% |
Max Drawdown (1Y)Largest decline over 1 year | -59.49% | -16.40% | -43.09% |
Max Drawdown (3Y)Largest decline over 3 years | -73.96% | -27.23% | -46.73% |
Max Drawdown (5Y)Largest decline over 5 years | -80.19% | -35.07% | -45.12% |
Max Drawdown (10Y)Largest decline over 10 years | -95.82% | -35.07% | -60.75% |
Current DrawdownCurrent decline from peak | -99.88% | -9.93% | -89.95% |
Average DrawdownAverage peak-to-trough decline | -90.11% | -7.95% | -82.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.26% | 6.07% | +33.19% |
Volatility
BIS vs. VGT - Volatility Comparison
ProShares UltraShort Nasdaq Biotechnology (BIS) has a higher volatility of 12.40% compared to Vanguard Information Technology ETF (VGT) at 8.42%. This indicates that BIS's price experiences larger fluctuations and is considered to be riskier than VGT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIS | VGT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.40% | 8.42% | +3.98% |
Volatility (6M)Calculated over the trailing 6-month period | 31.89% | 20.14% | +11.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.71% | 24.28% | +16.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.93% | 25.83% | +18.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.15% | 24.89% | +21.26% |
BIS vs. VGT - Expense Ratio Comparison
BIS has a 0.95% expense ratio, which is higher than VGT's 0.09% expense ratio.
Dividends
BIS vs. VGT - Dividend Comparison
BIS's dividend yield for the trailing twelve months is around 5.61%, more than VGT's 0.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 5.61% | 5.25% | 3.73% | 1.75% | 0.00% | 0.00% | 0.45% | 2.11% | 0.37% | 0.00% | 0.00% | 0.00% |
VGT Vanguard Information Technology ETF | 0.38% | 0.40% | 0.60% | 0.65% | 0.91% | 0.64% | 0.82% | 1.11% | 1.29% | 0.99% | 1.31% | 1.28% |
Frequently Asked Questions
BIS and VGT have a correlation of -0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIS has higher volatility (12.40%) compared to VGT (8.42%). In terms of maximum drawdown, BIS dropped -99.89% vs VGT's -54.63%.
On 10-year performance, VGT leads with 24.06% vs -24.02% for BIS. On fees, VGT is cheaper at 0.09% per year. On volatility, VGT has been the lower-risk option at 8.42%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, VGT has performed better with a 24.06% return vs -24.02%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VGT is cheaper with a 0.09% expense ratio, compared with 0.95% for BIS.
BIS has the higher dividend yield at 5.61%, compared with 0.38% for VGT.
BIS is categorized as Leveraged Equities, while VGT is Technology Equities. BIS tracks NASDAQ Biotechnology Index (-200%), while VGT tracks MSCI USA IMI Information Technology 25/50 Index. They also come from different issuers: ProShares and Vanguard. Their fees differ too: 0.95% for BIS and 0.09% for VGT.
VGT currently has the higher Sharpe Ratio (1.31 vs -1.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIS and VGT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer